Finance

Lists
603676:SHA
Xizang Weixinkang Pharmaceutical Co Ltd
CNÂ¥9.17
-1.19%
(-0.11) 1D
Sep 2, 10:59:15 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603676...
Open
CNÂ¥9.26
High
CNÂ¥9.26
Low
CNÂ¥9.14
Mkt. cap
3.99B
Avg. vol.
2.71M
Volume
762.90K
Dividend
3.57%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 29, 2026
P/E ratio
20.58
52-wk high
CNÂ¥13.29
52-wk low
CNÂ¥7.82
EPS
CNÂ¥0.45
Shares outstanding
423.00M
No. of employees
763
Open
CNÂ¥9.26
High
CNÂ¥9.26
Low
CNÂ¥9.14
Mkt. cap
3.99B
Avg. vol.
2.71M
Volume
762.90K
Dividend
3.57%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 29, 2026
P/E ratio
20.58
52-wk high
CNÂ¥13.29
52-wk low
CNÂ¥7.82
EPS
CNÂ¥0.45
Shares outstanding
423.00M
No. of employees
763
About Xizang Weixinkang Pharmaceutical Co Ltd
CEO-
Employees763
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitewxkpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
276.24M
273.33M
322.14M
262.14M
Cost of goods sold
103.31M
113.44M
128.24M
110.54M
Cost of revenue
103.31M
113.44M
128.24M
110.54M
Research and development expenses
28.10M
34.04M
19.29M
23.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85.75M
111.67M
93.39M
84.37M
Operating expense
81.29M
180.88M
116.61M
72.80M
Total operating expenses
184.60M
294.32M
244.85M
183.35M
Operating income
91.65M
-20.98M
77.29M
78.80M
Other non operating income
10.90K
-224.74K
7.57K
-1.14M
EBT including unusual items
60.67M
15.41M
80.30M
86.94M
EBT excluding unusual items
95.80M
-17.48M
80.14M
80.73M
Income tax expense
24.28M
1.73M
11.96M
12.35M
Effective tax rate
40.02%
11.24%
14.89%
14.21%
Other operating expenses
-32.87M
36.84M
3.07M
-34.09M
Net income
36.39M
13.68M
68.34M
74.59M
Net profit margin
13.17%
5.00%
21.21%
28.45%
Earnings per share
-
-
-
-
Interest and investment income
4.35M
3.80M
2.94M
3.08M
Interest expense
-84.28K
-58.13K
-98.46K
-
Net interest expenses
4.27M
3.74M
2.84M
3.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
103.26M
-10.17M
88.10M
90.08M
Gain or loss from assets sale
88.96K
80.57K
-
4.48K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps